Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 14 |
---|
Ligand | BDBM46421 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_1460845 (CHEMBL3396502) |
---|
IC50 | 22000±n/a nM |
---|
Citation | Cumming, JG; Debreczeni, JÉ; Edfeldt, F; Evertsson, E; Harrison, M; Holdgate, GA; James, MJ; Lamont, SG; Oldham, K; Sullivan, JE; Wells, SL Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors. J Med Chem58:278-93 (2015) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 14 |
---|
Name: | Mitogen-activated protein kinase 14 |
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 41286.76 |
Organism: | Homo sapiens (Human) |
Description: | Q16539 |
Residue: | 360 |
Sequence: | MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG
TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
|
|
|
BDBM46421 |
---|
n/a |
---|
Name | BDBM46421 |
Synonyms: | 4-(4-methylphenoxy)-N-(4-pyridinylmethyl)benzenecarboxamide | 4-(4-methylphenoxy)-N-(4-pyridylmethyl)benzamide | 4-(4-methylphenoxy)-N-(pyridin-4-ylmethyl)benzamide | MLS000755676 | SMR000337350 | cid_4358655 |
Type | Small organic molecule |
Emp. Form. | C20H18N2O2 |
Mol. Mass. | 318.3691 |
SMILES | Cc1ccc(Oc2ccc(cc2)C(=O)NCc2ccncc2)cc1 |
Structure |
|